---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-22-000339"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2022-08-04T23:59:59+00:00"
generated_at: "2026-06-24T03:45:59.078880+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Globus Medical Q2 net sales $263.6M (+5% YoY); GAAP EPS $0.53, non-GAAP $0.56; Enabling Tech +41.7%

## Summary
- Net sales $263.6M, +5.0% as-reported and +6.5% constant currency vs Q2 2021.
- GAAP net income $54.6M (+31.4% YoY); diluted EPS $0.53 vs $0.40.
- Non-GAAP diluted EPS $0.56; adjusted EBITDA $91.9M (34.9% of sales).
- Enabling Technologies sales $29.4M (+41.7%) driven by robotics and Excelsius 3D.
- Reaffirmed FY2022 guidance: net sales $1.025B, non-GAAP diluted EPS $2.10.

## SEC filing metadata
- accession: 0001562762-22-000339
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2022-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000156276222000339/0001562762-22-000339-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000156276222000339/gmed-20220804x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-22-000339
- JSON: https://secwatch.observer/filing/0001562762-22-000339.json
- Plain text: https://secwatch.observer/filing/0001562762-22-000339.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.